Peer Review History

Original SubmissionAugust 31, 2020
Decision Letter - Yukiko Washio, Editor

PONE-D-20-27314

Psychosocial stress is associated with neuroendocrine biomarker concentrations among Black women living with or without HIV

PLOS ONE

Dear Dr. Levy,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Yukiko Washio, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Thank you for stating the following in the Competing Interests section:

"The authors have declared that no competing interests exist."

We note that one or more of the authors are employed by a commercial company: Westat.

(1) Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

(2) Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: “Psychosocial stress is associated with neuroendocrine biomarker concentrations

among Black women living with or without HI" is a paper whose topic may be of interest to the readership of PLOS ONE. The current study takes an intersectional approach to examine the association between self-reported psychosocial stress and neuroendocrine biomarkers of stress among women living with HIV, with an emphasis on black women. This study contributes to the literature by focusing on understanding the potential mechanisms of cardiovascular disease among cis-gender women living with HIV, a population that has been neglected in research to date. This study supports and extends previous research by highlighting the role of stress, especially racial and gender-based harassment on the physiological functioning of black women living with HIV. However, I have one major concern about the misalignment between how the article is framed in the introduction and the results that are presented. What follows are my concerns and points of clarification.

Overall Concern

The authors frame the manuscript as an examination of stress in Black women living with HIV. This is present in the title and introduction. However, the authors actually examined the role of self-reported stress and biomarkers of stress among women of all ethnicities. As a result of this misalignment, the point of the paper gets lost. It appears the original research question was related to all women living with HIV as compared to those who were HIV-negative and that the sub-analysis among black women was part of a fishing expedition given the null findings of the main analysis.

Given the authors interest in understanding how race and gender-related stress impact health of women living with HIV, I recommend that the authors dedicate some time to fully addressing how racism and sexism may impact the stress and health of Black women living with HIV in the introduction; remove the analysis which included all women (currently the main analysis), and focus on the analysis examining the associations of interests among Black women living with HIV and those who were not. Alternatively, the authors might keep the analysis which includes all women as and include it with the other supplementary analysis that was conducted – however, I believe it would be best just to remove it.

Introduction

1. I would be careful when addressing how stress related to socioeconomic status is related to the health of women living with HIV. The authors do not measure socioeconomic status is a meaningful way (above or below $30,000 is not an approximate proxy for SES), therefore, the introduction should focus on the potential impact of racism, sexism, posttraumatic stress, and other perceived stress on the health of this population.

Methods

1. It should be noted that no traumatic event was indexed on the PTSD checklist. This is problematic because the “Stressful event” referenced in the questions may not meet criteria for a traumatic event. This is briefly noted in the limitations but should also be stated in the methods. The authors may also consider removing this measure all together since it is very difficult to differentiate between generalized anxiety and PTSD with understanding the index event. For example, the sample questions presented by the authors is “Avoiding activities or situations because they reminded you of a stressful experience”. It is difficult to distinguish between social anxiety and re-experiencing a traumatic event if there is no index event. Alternatively, the authors may separate the scores for racial and gender harassment and use them as separate indicators in the LCA. Therefore, they could still have three indicators of the LCA if they removed the PTSD scale.

2. Please clarify that the subgroup analysis conducted among Black women is stratified by HIV status.

Discussion

1. Again, the authors should be careful with attributing the stress of participants to SES, since SES was not appropriately measured and not included in the measurement of stress.

2. Also, the authors should be careful not to attributed PTSD symptoms to the experiences of violence reported by the participants, since no index event was reported for the checklist.

Decision: Revise and Resubmit, with Major Revisions

Reviewer #2: The focus of the study was to examine the relationship between psychosocial stress and neuroendocrine biomarkers among women living with HIV. This article was well written and presents novel findings about a population which experience marginalization due to race, gender, and HIV status. The major concerns about this article are how the findings are framed and the choice in analytic methods. I offer a few suggestions for improving the manuscript.

Major comments

- The premise of the article is that racial discrimination could lead to differential outcomes among Black women, however the stress measures were general. For the one measure that specifically identified race-related stress, the racial and gender harassment scale, participants across racial groups had similar scores. Additionally, biomarker scores were similar across group. Temper findings and lead with the null finding that the relation between psychosocial stress latent profile and biomarker index was null, however there is some evidence that this relationship varies by racial category. In the discussion explain why the main finding and subgroup analyses among WLWH compared to HIV-negative women, were null.

- The sub-group analyses within Black women are rather small and do not provide anything meaningful beyond what is gleaned from the full sample of Black women. Cut the analyses for the WLWH and HIV negative women.

- Linear regression was used for multivariable analyses, however the biomarker index is not truly a continuous variable. Ordinal logistic regression should be used instead.

Minor comments

- Page 11, Line 219: If possible, find an alternate item to use as the example that does not include the racial slurs.

- Page 11, Line 224: Describe race/ethnicity categories and rationale for all the participants who were grouped in the other category. Were sensitivity analyses conducted to examine whether including multiracial participants who checked Black into the analyses for participants who solely checked Black? Often multiracial people who are Black and another race are racialized as Black and may have similar stressors.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PLOS ONE d-20-27314.edited.docx
Revision 1

Dear Dr. Washio,

Thank you for the opportunity to revise this manuscript, titled “Psychosocial stress and neuroendocrine biomarker concentrations among women living with or without HIV” (PONE-D-20-27314). Please find below indication of where changes were made in response to the comments provided by the reviewers. We are happy to make additional revisions as deemed necessary.

Reviewer 1

Comment: “Psychosocial stress is associated with neuroendocrine biomarker concentrations among Black women living with or without HIV" is a paper whose topic may be of interest to the readership of PLOS ONE. The current study takes an intersectional approach to examine the association between self-reported psychosocial stress and neuroendocrine biomarkers of stress among women living with HIV, with an emphasis on black women. This study contributes to the literature by focusing on understanding the potential mechanisms of cardiovascular disease among cis-gender women living with HIV, a population that has been neglected in research to date. This study supports and extends previous research by highlighting the role of stress, especially racial and gender-based harassment on the physiological functioning of black women living with HIV. However, I have one major concern about the misalignment between how the article is framed in the introduction and the results that are presented. What follows are my concerns and points of clarification.

Response: We thank Reviewer 1 for reviewing this manuscript and for providing comprehensive and thoughtful feedback. We have reframed the manuscript and provided additional information to address this reviewer’s questions and concerns. Please see our responses below each specific comment for additional details regarding our revisions, including those pertaining to the major concern about the misalignment between how the article is framed and the introduction and results that are presented.

Comment: Overall Concern: The authors frame the manuscript as an examination of stress in Black women living with HIV. This is present in the title and introduction. However, the authors actually examined the role of self-reported stress and biomarkers of stress among women of all ethnicities. As a result of this misalignment, the point of the paper gets lost. It appears the original research question was related to all women living with HIV as compared to those who were HIV-negative and that the sub-analysis among black women was part of a fishing expedition given the null findings of the main analysis.

Given the authors interest in understanding how race and gender-related stress impact health of women living with HIV, I recommend that the authors dedicate some time to fully addressing how racism and sexism may impact the stress and health of Black women living with HIV in the introduction; remove the analysis which included all women (currently the main analysis), and focus on the analysis examining the associations of interests among Black women living with HIV and those who were not. Alternatively, the authors might keep the analysis which includes all women as and include it with the other supplementary analysis that was conducted – however, I believe it would be best just to remove it.

Response: We thank the reviewer for these comments. As pre-planned, our primary objective was to “evaluate associations between psychosocial stress (i.e., perceived stress, posttraumatic stress, and experiences of race- and gender-based harassment) and a composite neuroendocrine biomarker index among WLWH and HIV-negative women” of all races and ethnicities (line 102 in the version with tracked changes). We “hypothesized that this association would be stronger among WLWH compared with HIV-negative women” (line 107 in the version with tracked changes). Rather than representing a fishing expedition, our analyses conducted among the subgroup of Black participants were pre-planned based on (1) the large proportion of WLWH in the United States, DC, and this study population who identify as Black; (2) the body of empirical research demonstrating the relationship between racism or racial microaggressions and stress; and (3) our inclusion of the Racialized Sexual Harassment Scale as a measure of harassment related to one’s race or ethnicity and/or gender, which has greater relevance to women of color. We have clarified in the Introduction that this subgroup analysis was secondary: “Given that Black WLWH disproportionately experience stress related to intersecting social-structural vulnerabilities [60-62], we also conducted a secondary subgroup analysis in which we evaluated this association specifically among Black women” (line108 in the version with tracked changes). We have reframed this manuscript to more accurately reflect our original objectives and have revised the title to “Psychosocial stress and neuroendocrine biomarker concentrations among women living with or without HIV.” Reflecting these objectives, we have opted to retain the overall study population (of all races or ethnicities) in our analysis and to continue to report both results for the overall study sample and the subset of Black participants.

The introduction is now better aligned with this focus. The second paragraph focuses on psychosocial stress among WLWH in general, and we further expand upon this paragraph in the third paragraph to address how racism and sexism may impact the stress and health of Black women and Black WLWH, consistent with our secondary objective: “At the end of 2019, 57% of all WLWH in the United States were Black women [20]. Among Black women, discrimination attributed to racism and sexism is common and is associated with elevated stress [21, 22]. Gendered racism, or the simultaneous experience of both racism and sexism, is an inherent stressor that can negatively affect personal relationships, professional and economic opportunities, and mental and physical health outcomes among Black women [23-26]. Gendered racism causes psychosocial stress both directly and through increased vulnerability to other stressors [21, 23-25]. Further, among Black WLWH, the effects of gendered racism and HIV-based discrimination can compound one another, representing key social-structural barriers to HIV care [27].”

Our discussion section is also better aligned with this focus, as it begins with: “In this study, we found a null association between psychosocial stress and a composite neuroendocrine biomarker index among the overall sample of WLWH and HIV-negative women and did not find evidence of a difference in this association between WLWH and HIV-negative women. However, our data demonstrate that higher levels of self-reported psychosocial stress were associated with more extreme concentrations of neuroendocrine biomarkers specifically among Black WLWH and HIV-negative women, although this was only the case among monoracial Black participants (and not among all Black participants, including those who identified with at least one other race).”

Comment: Introduction: 1. I would be careful when addressing how stress related to socioeconomic status is related to the health of women living with HIV. The authors do not measure socioeconomic status is a meaningful way (above or below $30,000 is not an approximate proxy for SES), therefore, the introduction should focus on the potential impact of racism, sexism, posttraumatic stress, and other perceived stress on the health of this population.

Response: We agree with this comment and have removed mention of socioeconomic status from the introduction. The introduction focuses on the potential impact of perceived stress, posttraumatic stress, racism, and sexism, reflecting the key measures from this study.

Comment: Methods: 1. It should be noted that no traumatic event was indexed on the PTSD checklist. This is problematic because the “Stressful event” referenced in the questions may not meet criteria for a traumatic event. This is briefly noted in the limitations but should also be stated in the methods. The authors may also consider removing this measure all together since it is very difficult to differentiate between generalized anxiety and PTSD with understanding the index event. For example, the sample questions presented by the authors is “Avoiding activities or situations because they reminded you of a stressful experience”. It is difficult to distinguish between social anxiety and re-experiencing a traumatic event if there is no index event. Alternatively, the authors may separate the scores for racial and gender harassment and use them as separate indicators in the LCA. Therefore, they could still have three indicators of the LCA if they removed the PTSD scale.

Response: We thank the reviewer for raising this point and have added language to the methods section indicating that no traumatic event was indexed on the PTSD checklist: “The PCL-C asks about symptoms in relation to generic stressful experiences rather than in relation to a specific index event. Although this aspect of the PCL-C facilitates its use in different populations, it also limits its ability to identify sources of stress and determine whether stressful experiences meet criteria for a traumatic event” (line 206 in the version with tracked changes). We also acknowledged this limitation in the discussion section: “Although we assessed recent experiences of race- and gender-related harassment, our use of general symptom-based measures for perceived stress and posttraumatic stress limited our ability to identify the sources of those types of stress reported by participants” (line 556 in the version with tracked changes). Despite this limitation, we think that stress in relation to stressful experiences in general is of relevance to our research question and that there is value in retaining this measure in the analysis, even if PCL-C items were not assessed with respect to a specific traumatic event. We opted to retain the PCL-C measure in our analysis as planned.

Comment: 2. Please clarify that the subgroup analysis conducted among Black women is stratified by HIV status.

Response: We have clarified that the subgroup analysis conducted among Black women was stratified by HIV status: “Regression analyses were further conducted separately among all non-Hispanic Black participants, non-Hispanic Black WLWH, and non-Hispanic Black HIV-negative women” (line 329 in the version with tracked changes).

Comment: Discussion: 1. Again, the authors should be careful with attributing the stress of participants to SES, since SES was not appropriately measured and not included in the measurement of stress.

Response: We agree with this comment and have removed the previous text that attributed stress of participants to SES (previously, “With approximately two-thirds of the sample having had an annual income <$30,000 and approximately half having had at most a high school education, it is likely that challenges associated with low socioeconomic status contributed to stressors experienced by women in this study.”).

Comment: 2. Also, the authors should be careful not to attributed PTSD symptoms to the experiences of violence reported by the participants, since no index event was reported for the checklist.

Response: We agree with this comment and have removed the previous text that attributed PTSD symptoms to experiences of violence reported by the participants (previously, “Regarding possible sources of posttraumatic stress, 51% of WLWH and 55% of HIV-negative women in the WIHS have experienced physical violence, and 38% of WLWH and 40% of HIV-negative women in the WIHS have experienced sexual abuse.”).

Reviewer 2

Comment: The focus of the study was to examine the relationship between psychosocial stress and neuroendocrine biomarkers among women living with HIV. This article was well written and presents novel findings about a population which experience marginalization due to race, gender, and HIV status. The major concerns about this article are how the findings are framed and the choice in analytic methods. I offer a few suggestions for improving the manuscript.

Response: We thank Reviewer 2 for reviewing this manuscript and for providing comprehensive and thoughtful feedback. We have reframed the manuscript and provided additional information to address this reviewer’s questions and concerns. Please see our responses below each specific comment for additional details regarding our revisions, including those pertaining to how the findings are framed and the choice in analytic methods.

Comment: Major comments: The premise of the article is that racial discrimination could lead to differential outcomes among Black women, however the stress measures were general. For the one measure that specifically identified race-related stress, the racial and gender harassment scale, participants across racial groups had similar scores. Additionally, biomarker scores were similar across group. Temper findings and lead with the null finding that the relation between psychosocial stress latent profile and biomarker index was null, however there is some evidence that this relationship varies by racial category. In the discussion explain why the main finding and subgroup analyses among WLWH compared to HIV-negative women, were null.

Response: We thank the reviewer for these comments. We have reframed this manuscript to more accurately reflect our original objectives and have revised the title to “Psychosocial stress and neuroendocrine biomarker concentrations among women living with or without HIV.” We have tempered findings and now lead with the null finding; at the beginning of the Discussion section, we state: “In this study, we found a null association between psychosocial stress and a composite neuroendocrine biomarker index among the overall sample of WLWH and HIV-negative women and did not find evidence of a difference in this association between WLWH and HIV-negative women. However, our data demonstrate that higher levels of self-reported psychosocial stress were associated with more extreme concentrations of neuroendocrine biomarkers specifically among Black WLWH and HIV-negative women, although this was only the case among monoracial Black participants (and not among all Black participants, including those who identified with at least one other race).” We also provide a possible reason for why the main findings were null: “Null findings among the overall study population may have been related to the use of general measures for perceived and posttraumatic stress. Such general forms of stress may have had limited influence on the neuroendocrine biomarkers evaluated in this study” (line 587 in the version with tracked changes). It may also be related to the smaller sample size, which limited our ability to detect significant differences, unless quite large. As mentioned in the Conclusion paragraph, “Future research with larger study samples should evaluate whether this association differs by HIV status among Black women, by race or ethnicity among WLWH, or by gender among PLWH” (line 623 in the version with tracked changes). Regarding the finding that self-reported stress measures and biomarker scores did not appear different across racial and ethnic groups, there were only 5 non-Hispanic white participants and 5 Hispanic participants (and 31 biracial, mixed-race, or multiracial participants who identified with different combinations of races), limiting our capacity to detect differences by race or ethnicity in this study.

Comment: The sub-group analyses within Black women are rather small and do not provide anything meaningful beyond what is gleaned from the full sample of Black women. Cut the analyses for the WLWH and HIV negative women.

Response: In the introduction section, we have specified that “we hypothesized that this association would be stronger among WLWH compared with HIV-negative women” (line 107 in the version with tracked changes). Although the sample sizes for WLWH and HIV-negative women are small when restricted to Black participants, we have opted to retain these findings in the manuscript because a positive association was consistently found in separate analyses among all Black women, Black WLWH, and Black HIV-negative women. Each regression model converged and the association between high psychosocial stress and a higher neuroendocrine biomarker index score was significant in each of these subgroups. Although we would have likely been unable to detect a statistically significant difference in this association between WLWH and HIV-negative women, a reader may want to know whether there was at least some evidence of this association differing by HIV status, which we did not find. In the discussion section, we state this limitation that “sample sizes were relatively small in analyses stratified by HIV status and/or restricted to non-Hispanic Black participants, which resulted in less precise estimates for associations” (line 600 in the version with tracked changes).

Comment: Linear regression was used for multivariable analyses, however the biomarker index is not truly a continuous variable. Ordinal logistic regression should be used instead.

Response: We thank the reviewer for raising this point. Although we agree that ordinal logistic regression is an alternative choice, we believe that linear regression is also appropriate, particularly in the context of a smaller sample size. We have provided our rationale in the manuscript: “Although ordinal regression is a possible alternative, because the difference between the scores of 0 and 1, 1 and 2, 2 and 3, and 3 and 4 have the same interpretation (i.e., one additional biomarker in the high-risk range), we were able to appropriately harness the greater statistical power of linear regression for this analysis. This increased power is particularly useful in this study with a smaller sample size. This approach has been applied successfully elsewhere [72-76]" (line 315).

In the following similar studies, linear regression was used successfully to model allostatic load, the composite biomarker index score on which our study’s outcome measure was based:

1. Van Dyke ME, Baumhofer NK, Slopen N, Mujahid MS, Clark CR, Williams DR, et al. Pervasive discrimination and allostatic load in African American and white adults. Psychosom Med. 2020;82: 316-323.

2. Currie CL, Copeland JL, Metz GA, Chief Moon-Riley K, Davies CM. Past-year racial discrimination and allostatic load among indigenous adults in Canada: the role of cultural continuity. Psychosom Med. 2020;82: 99-107.

3. Freire A do NF, Barbosa JF de S, Pereira DS, Gomes CDS, Guerra RO. Allostatic load and stress biomarkers in a sample of community-dwelling older adults. Arch Gerontol Geriatr. 2020;87: 104006.

4. Hux VJ, Catov JM, Roberts JM. Allostatic load in women with a history of low birth weight infants: the National Health and Nutrition Examination Survey. J Womens Health (Larchmt). 2014;23: 1039-1045.

5. Schenk HM, Jeronimus BF, van der Krieke L, Bos EH, de Jonge P, Rosmalen JGM. Associations of positive affect and negative affect with allostatic load: a lifelines cohort study. Psychosom Med. 2018;80: 160-166.

Comment: Minor comments: Page 11, Line 219: If possible, find an alternate item to use as the example that does not include the racial slurs.

Response: We have replaced this item with an alternate item that does not include racial slurs: “Someone said they expected you to behave certain ways because of your gender and ethnicity (for example, expected you as a Black or Latina woman to wear inappropriate clothes, expected you as an Asian man to be self-controlled and disciplined, as an Asian woman to try to please others, as a Latino man that you would be unfaithful in relationships, etc.)” (line 238 in the version with tracked changes).

Comment: Page 11, Line 224: Describe race/ethnicity categories and rationale for all the participants who were grouped in the other category. Were sensitivity analyses conducted to examine whether including multiracial participants who checked Black into the analyses for participants who solely checked Black? Often multiracial people who are Black and another race are racialized as Black and may have similar stressors.

Response: We thank the reviewer for raising this point. We have added our rationale for including participants who identified with more than one race in a separate category and have also added a sensitivity analysis to examine whether results were influenced by inclusion of multiracial participants who checked Black in the subgroup analysis among Black participants. In the methods section, we state: “Recognizing that Black individuals who identify with at least one other race (i.e., biracial, mixed-race, or multiracial individuals) are often racialized as Black, yet have unique experiences associated with existing at the intersections of multiple racial identities, we conducted these subgroup analyses once among participants who identified exclusively as Black and again among all participants who identified as Black regardless of whether they also identified with another race” (line 331 in the version with tracked changes). In the results section, we report that results were null after inclusion of Black participants who identified with at least one other race: “Associations were attenuated and none remained significant in analyses among the subgroup of all non-Hispanic Black women, which included those who identified exclusively as Black plus those who also identified with another race (data not shown)” (line 494 in the version with tracked changes). In the first paragraph of the discussion, we acknowledge this finding: “our data demonstrate that higher levels of self-reported psychosocial stress were associated with more extreme concentrations of neuroendocrine biomarkers specifically among Black WLWH and HIV-negative women, although this was only the case among monoracial Black participants (and not among all Black participants, including those who identified with at least one other race)” (line 537 in the version with tracked changes).

Attachments
Attachment
Submitted filename: PLOS One - WIHS Pilot - Response to Reviewers - 8.21.21.docx
Decision Letter - Yukiko Washio, Editor

Psychosocial stress and neuroendocrine biomarker concentrations among women living with or without HIV

PONE-D-20-27314R1

Dear Dr. Levy,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yukiko Washio, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript has addressed all of my comments and is acceptable for publication in PLOS One. Thank you for allowing me the opportunity to review.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Yukiko Washio, Editor

PONE-D-20-27314R1

Psychosocial stress and neuroendocrine biomarker concentrations among women living with or without HIV

Dear Dr. Levy:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yukiko Washio

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .